Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 24 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

7%

1 of 15 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
15(78.9%)
Phase 2
2(10.5%)
Phase 1
1(5.3%)
Phase 3
1(5.3%)
19Total
N/A(15)
Phase 2(2)
Phase 1(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials
NCT07359677Not ApplicableCompleted

High-frequency Alternating Current Stimulation for Neurophatic Pain in Spinal Cord Injury

Role: collaborator

NCT07440459Completed

Promoting Neuroplastic Mechanisms With Modeling-based Optimization of a Novel Robot-asisted Walking Rehabilitation Therapy

Role: collaborator

NCT07036107Not ApplicableRecruiting

A Trial on the Clinical and Socioeconomic Impact of Wearable Exoskeletons for Spinal Cord Injury Rehabilitation in the Spanish Healthcare System

Role: collaborator

NCT06772077Not ApplicableRecruiting

Safety and Usability of the ATLAS 2030 Exoskeleton in Pediatric Patients With Spinal Cord Injury

Role: collaborator

NCT05858099Active Not Recruiting

The Early Detection and Progression of Subclinical Atherosclerosis in Psoriasis

Role: collaborator

NCT05757830Not ApplicableCompleted

PURO - PUlmonary Rehabilitation With O-RAGT Platform

Role: collaborator

NCT05904600Not ApplicableUnknown

Respiratory Muscle Training in Adults With Spinal Cord Injury

Role: collaborator

NCT02952053Not ApplicableCompleted

Can Myotonometry Quantify Dry Needling Effectiveness on Myofascial Trigger Points?

Role: collaborator

NCT05622994Phase 2Unknown

Effects of CB1 Antagonist/Reverse Agonist Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury

Role: lead

NCT05398913Phase 1Completed

Effects of Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury

Role: lead

NCT01329757Phase 3Completed

Efficacy and Safety of Growth Hormone Treatment in Spinal Cord Injury

Role: lead

NCT04383873Not ApplicableCompleted

Effectiveness Analysis of Armeo Spring Device as a Rehabilitation Treatment in Spinal Cord Injured Patients

Role: lead

NCT03477123Not ApplicableCompleted

Evaluation of Robotic Exoskeletons Therapy for Gait Rehabilitation in Patients With Incomplete Spinal Cord Injury.

Role: lead

NCT04241406Not ApplicableCompleted

Transcutaneous Spinal Cord Stimulation in Healthy Subjects to Activate Central Pattern Generator

Role: collaborator

NCT04117256Not ApplicableCompleted

Transcranial Versus Suboccipital Direct Current Stimulation

Role: collaborator

NCT02837458Not ApplicableCompleted

Effect of High Frequency Electrical Currents in Healthy Subjects.

Role: collaborator

NCT02657681Phase 2Completed

Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)

Role: collaborator

NCT02493543Unknown

Autoantibodies on Spinal Cord Injury

Role: lead

NCT02575586Not ApplicableCompleted

Effectiveness of Deep Dry Needling on Muscle Tone in Healthy Subjects

Role: collaborator

NCT02919150Completed

Myotonometric Measurement of Myofascial Trigger Points: Reliability, Validity and Sensitivity

Role: collaborator